Opendata, web and dolomites

BREATH

BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BREATH project word cloud

Explore the words cloud of the BREATH project. It provides you a very rough idea of what is the project "BREATH" about.

substantial    380    manufacture    clients    particles    lung    innovation    profitability    companies    health    diseases    quality    initially    detect    completely    cancer    designing    airways    time    economic    patients    responsible    small    risk    stage    air    respiratory    breathing    faster    figure    difficult    billion    alternative    prove    pulmonary    pexa    burden    actively    asthma    disease    diagnostic    once    kits    reliability    services    chemical    usually    painful    academia    disposable    biomarkers    professionals    breath    commercial    feasibility    provides    healthcare    extensive    tuberculosis    brings    diagnosed    instrument    service    collect    consists    deaths    obstructive    fundamentally    diagnose    phase1    diagnosis    device    outcome    invasive    easily    patient    market    each    assessing    repeatable    competitiveness    checking    chronic    stages    socio    stand    quantitative    alone    million    pharmaceutical    exhaled   

Project "BREATH" data sheet

The following table provides information about the project.

Coordinator
PEXA AB 

Organization address
address: ERIK DAHLBERGSGATAN 11 A
city: GOTEBORG
postcode: 411 26
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website http://pexa.se/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PEXA AB SE (GOTEBORG) coordinator 50˙000.00

Map

 Project objective

Each year in Europe, lung diseases are responsible of more than one million deaths and extensive costs estimated at €380 billion. These respiratory diseases, such as chronic obstructive pulmonary disease, lung cancer, asthma and tuberculosis, are very difficult to detect and usually diagnosed in late-stages once there is a significant burden of disease within them. BREATH project consists to develop, manufacture and market a research instrument to study and to diagnose respiratory diseases. The concept is based on a completely new method to collect and analyse particles via exhaled air in the small airways to easily identify chemical changes and potential biomarkers for respiratory diseases. The PExA method has the potential to fundamentally change the way lung diseases are diagnosed and treated today by offering a best alternative of the existing methods on market, which brings a substantial commercial potential. By doing a simple breathing test and without any potential risk for the patients, PExA's instrument provides a quantitative, reliable, user friendly, non-invasive, less painful, faster, repeatable method for early-stage diagnosis. PExA's clients are all those who are currently actively looking for biomarkers to figure out the patient's health conditions such as lung researchers and healthcare professionals within health services, academia and pharmaceutical companies initially in the EU and then the US. The objectives of BREATH project Phase1 are to: (1) prove through a feasibility study the potential to develop a real-time and stand-alone analysis/diagnostic device; (2) enhance the competitiveness and profitability of the service by improving the quality and reliability of the system via (i) the checking system, (ii) designing and developing our own disposable kits. The outcome will be a feasibility study assessing the socio-economic, commercial and technical aspects of the innovation that will be used to define the activities of Phase II.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BREATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BREATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.4.;H2020-EU.2.3.1.)

FlexiBiome (2018)

Next Generation Microbiome Platform

Read More  

SEQURE (2018)

Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer

Read More  

sFilm-FS (2018)

Fibrin sealant for anastomotic leaks and haemostasis

Read More